Reported about 1 month ago
Abbott Laboratories has slightly increased its profit forecast following strong quarterly earnings driven by high demand for its continuous glucose monitors and other medical devices, resulting in a 21% sales growth in this sector. The company expects annual profits between $4.64 to $4.70 per share, which is an improvement from its previous estimate. Despite challenges in its pediatric nutrition business, overall sales reached $10.64 billion, exceeding analyst expectations.
Source: YAHOO